Bausch & Lomb Corp (NYSE: BLCO)

Bausch + Lomb Corporation, commonly known as Bausch + Lomb, is a prominent player in the global eye health industry, dedicated to enhancing and protecting the gift of sight for millions of people worldwide. The company's mission is to enable people to see better and live better, and it achieves this by developing, manufacturing, and marketing a wide range of products primarily focused on eye health. These products are marketed in approximately 100 countries, indicating the company's global reach.

Bausch + Lomb's operations are divided into three key segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment includes consumer eye care and contact lens businesses, offering a variety of products such as contact lenses, eye drops, and eye care solutions. The Pharmaceuticals segment boasts a broad line of proprietary and generic pharmaceutical products used for post-operative treatments and treatments for several eye conditions, including glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. Lastly, the Surgical segment provides medical device equipment, consumables, and technologies for the treatment of various eye conditions, such as cataracts, corneal, vitreous, and retinal eye conditions.

The company's primary products include a range of contact lenses, such as SiHy Daily, Bausch + Lomb ULTRA, and Biotrue ONEday, as well as a variety of eye drops, including Lumify, MIEBO, and XIPERE. Additionally, Bausch + Lomb offers pharmaceutical products for treating eye conditions like glaucoma, eye inflammation, and dry eyes, with products such as XIIDRA, Vyzulta, and Lotemax. The surgical products offered by the company include a range of medical devices and technologies for cataract and corneal refractive surgery, like the Stellaris Elite vision enhancement system and the VICTUS femtosecond laser.

As a leading global eye health company, Bausch + Lomb competes with other prominent eye health companies, such as Johnson & Johnson Vision and Alcon. The company's strong brand reputation, innovative products, and global reach set it apart from its competitors, making it a key player in the industry.

Bausch + Lomb's customers include a diverse range of eye care professionals, including ophthalmologists, optometrists, and opticians, as well as consumers who purchase its products directly or through retailers. The company's products are used to treat a variety of eye conditions, such as cataracts, glaucoma, eye inflammation, dry eyes, and retinal diseases.